• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾素-血管紧张素系统阻滞剂联合治疗:氨氯地平会取代氢氯噻嗪吗?

Combination therapy with renin-angiotensin system blockers: will amlodipine replace hydrochlorothiazide?

作者信息

Tejada Thor, Fornoni Alessia, Lenz Oliver, Materson Barry J

机构信息

Division of Nephrology and Hypertension, Department of Medicine, Miller School of Medicine, University of Miami OPPRP (D-54), PO Box 016960, Miami, FL 33101, USA.

出版信息

Curr Hypertens Rep. 2007 Aug;9(4):284-90. doi: 10.1007/s11906-007-0052-0.

DOI:10.1007/s11906-007-0052-0
PMID:17686378
Abstract

Amlodipine is a highly effective and safe antihypertensive dihydropyridine calcium channel blocker. It is even more effective when used in combination with other antihypertensive medications, including hydrochlorothiazide. When antihypertensive calcium channel blockers were first introduced, evidence in the laboratory that they had some natriuretic properties was adduced to suggest that they would be "the diuretics of the 1990s." This turned out not to be the case. Because of its clinical efficacy, amlodipine is frequently used in fixed-dose combination products, but it is not likely to replace hydrochlorothiazide.

摘要

氨氯地平是一种高效且安全的抗高血压二氢吡啶类钙通道阻滞剂。与包括氢氯噻嗪在内的其他抗高血压药物联合使用时,它的效果更佳。当抗高血压钙通道阻滞剂首次被引入时,实验室证据表明它们具有一定的利钠特性,据此有人提出它们将成为“20世纪90年代的利尿剂”。但事实并非如此。由于其临床疗效,氨氯地平经常被用于固定剂量复方制剂中,但它不太可能取代氢氯噻嗪。

相似文献

1
Combination therapy with renin-angiotensin system blockers: will amlodipine replace hydrochlorothiazide?肾素-血管紧张素系统阻滞剂联合治疗:氨氯地平会取代氢氯噻嗪吗?
Curr Hypertens Rep. 2007 Aug;9(4):284-90. doi: 10.1007/s11906-007-0052-0.
2
Combination therapy with amlodipine/benazapril (CCB/ACEI) superior to hydrochlorothiazide/benazapril in high-risk hypertensive patients.氨氯地平/贝那普利联合治疗(CCB/ACEI)在高危高血压患者中优于氢氯噻嗪/贝那普利。
Cardiovasc J Afr. 2008 May-Jun;19(3):163.
3
Role of valsartan, amlodipine and hydrochlorothiazide fixed combination in blood pressure control: an update.缬沙坦、氨氯地平和氢氯噻嗪固定复方制剂在血压控制中的作用:最新进展
Vasc Health Risk Manag. 2010 Apr 15;6:253-60. doi: 10.2147/vhrm.s6805.
4
Effect of switching from amlodipine to combination therapy with telmisartan and low-dose hydrochlorothiazide.从氨氯地平转换为替米沙坦与小剂量氢氯噻嗪联合治疗的效果。
Hypertens Res. 2009 Sep;32(9):748-52. doi: 10.1038/hr.2009.101. Epub 2009 Jul 10.
5
Benazepril plus amlodipine or hydrochlorothiazide for hypertension.贝那普利联合氨氯地平或氢氯噻嗪治疗高血压
N Engl J Med. 2009 Mar 12;360(11):1147-8; author reply 1149-50. doi: 10.1056/NEJMc082725.
6
Prior Medications and the Cardiovascular Benefits From Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High-Risk Hypertensive Patients.高危高血压患者中,联合使用血管紧张素转换酶抑制剂加钙通道阻滞剂的心血管益处与先前用药情况。
J Am Heart Assoc. 2018 Jan 4;7(1):e006940. doi: 10.1161/JAHA.117.006940.
7
Benazepril plus amlodipine or hydrochlorothiazide for hypertension.贝那普利联合氨氯地平或氢氯噻嗪治疗高血压
N Engl J Med. 2009 Mar 12;360(11):1148; author reply 1149-50.
8
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.贝那普利联合氨氯地平或氢氯噻嗪用于高危患者高血压的治疗
N Engl J Med. 2008 Dec 4;359(23):2417-28. doi: 10.1056/NEJMoa0806182.
9
Triple combination therapy to improve blood pressure control: experience with olmesartan-amlodipine-hydrochlorothiazide therapy.三联疗法改善血压控制:使用奥美沙坦-氨氯地平-氢氯噻嗪治疗的经验。
Expert Opin Pharmacother. 2012 Dec;13(18):2687-97. doi: 10.1517/14656566.2012.745510. Epub 2012 Nov 21.
10
Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled Trials.长效和中效二氢吡啶类钙通道阻滞剂治疗高血压的效果:18项前瞻性、随机、阳性对照试验的系统评价和荟萃分析
J Cardiovasc Pharmacol Ther. 2018 Sep;23(5):433-445. doi: 10.1177/1074248418771341. Epub 2018 May 8.

引用本文的文献

1
One Molecule, Many Faces: Repositioning Cardiovascular Agents for Advanced Wound Healing.一种分子,多种用途:重新定位心血管药物以促进创面愈合。
Molecules. 2024 Jun 20;29(12):2938. doi: 10.3390/molecules29122938.
2
Clinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan.固定剂量复方制剂在高血压治疗中的临床应用:奈必洛尔/缬沙坦联用潜力的证据
Integr Blood Press Control. 2014 Nov 26;7:61-70. doi: 10.2147/IBPC.S50954. eCollection 2014.
3
Comparative effectiveness analysis of amlodipine/renin-angiotensin system blocker combinations.

本文引用的文献

1
Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis.抗高血压药物临床试验中的新发糖尿病:一项网状Meta分析。
Lancet. 2007 Jan 20;369(9557):201-7. doi: 10.1016/S0140-6736(07)60108-1.
2
Low-dose quadruple antihypertensive combination: more efficacious than individual agents--a preliminary report.低剂量四联降压组合:比单一药物更有效——初步报告
Hypertension. 2007 Feb;49(2):272-5. doi: 10.1161/01.HYP.0000254479.66645.a3. Epub 2006 Dec 18.
3
Efficacy and safety of amlodipine: a comparative study of hypertensive patients treated at primary- and specialised-care centres.
氨氯地平/肾素-血管紧张素系统抑制剂联合应用的疗效比较分析。
J Clin Hypertens (Greenwich). 2012 Sep;14(9):601-10. doi: 10.1111/j.1751-7176.2012.00695.x. Epub 2012 Aug 13.
氨氯地平的疗效与安全性:在初级保健中心和专科护理中心接受治疗的高血压患者的对比研究。
Clin Drug Investig. 2006;26(3):125-33. doi: 10.2165/00044011-200626030-00002.
4
Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).随机接受3种不同类别降压治疗的老年非糖尿病成年人的空腹血糖水平与新发糖尿病:抗高血压和降脂治疗预防心脏病发作试验(ALLHAT)的报告
Arch Intern Med. 2006 Nov 13;166(20):2191-201. doi: 10.1001/archinte.166.20.2191.
5
Effects of monotherapy and combination therapy on blood pressure control and target organ damage: a randomized prospective intervention study in a large population of hypertensive patients.单一疗法和联合疗法对血压控制及靶器官损害的影响:一项针对大量高血压患者的随机前瞻性干预研究。
J Clin Hypertens (Greenwich). 2006 Sep;8(9):634-41. doi: 10.1111/j.1524-6175.2006.05504.x.
6
The effect of carvedilol on metabolic parameters in patients with metabolic syndrome.卡维地洛对代谢综合征患者代谢参数的影响。
Int Heart J. 2006 May;47(3):421-30. doi: 10.1536/ihj.47.421.
7
Translocation of endothelial nitric oxide synthase: another feat of amlodipine, a cardiovascular jack-of-all-trades.内皮型一氧化氮合酶的转位:氨氯地平的另一项功能,一种心血管方面的多面手。
Cardiovasc Res. 2006 Aug 1;71(3):411-3. doi: 10.1016/j.cardiores.2006.06.006. Epub 2006 Jun 9.
8
Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials.颈动脉内膜中层厚度与降压治疗:随机对照试验的荟萃分析
Stroke. 2006 Jul;37(7):1933-40. doi: 10.1161/01.STR.0000227223.90239.13. Epub 2006 Jun 8.
9
Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.利尿剂在预防心力衰竭中的作用:预防心脏病发作的抗高血压和降脂治疗试验
Circulation. 2006 May 9;113(18):2201-10. doi: 10.1161/CIRCULATIONAHA.105.544031. Epub 2006 May 1.
10
Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine.在N(G)-硝基-L-精氨酸甲酯诱导的高血压大鼠主动脉中,钙通道阻滞剂通过增强内皮型一氧化氮合酶和抑制血管紧张素转换酶发挥抗炎和抗氧化作用:其血管保护作用超出氨氯地平和马尼地平的降压作用。
Hypertens Res. 2005 Aug;28(8):689-700. doi: 10.1291/hypres.28.689.